11.85
-0.18(-1.50%)
Currency In USD
| Previous Close | 12.03 |
| Open | 12.11 |
| Day High | 12.32 |
| Day Low | 11.78 |
| 52-Week High | 13.85 |
| 52-Week Low | 3.61 |
| Volume | 2.16M |
| Average Volume | 1.62M |
| Market Cap | 803.72M |
| PE | -39.5 |
| EPS | -0.3 |
| Moving Average 50 Days | 8.84 |
| Moving Average 200 Days | 8.76 |
| Change | -0.18 |
If you invested $1000 in CorMedix Inc. (CRMD) 10 years ago, it would be worth $371.47 as of May 09, 2025 at a share price of $11.85. Whereas If you bought $1000 worth of CorMedix Inc. (CRMD) shares 5 years ago, it would be worth $2,904.41 as of May 09, 2025 at a share price of $11.85.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025
GlobeNewswire Inc.
Apr 29, 2025 12:30 PM GMT
BERKELEY HEIGHTS, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that i
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
GlobeNewswire Inc.
Apr 08, 2025 11:30 AM GMT
‒ Q1 2025 Unaudited Net Revenue of $39.0 million ‒ ‒ Expected Q1 Adjusted EBITDA above $22.5 million ‒ ‒ Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million ‒ BERKELEY HEIGHTS, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Na
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Apr 02, 2025 12:30 PM GMT
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that m